Trials / Recruiting
RecruitingNCT05699629
Prospective Coronary Heart Disease Cohort
A Prospective Longitudinal Multi-Omics Cohort of Patients With Coronary Heart Disease Undergoing Coronary Angiography
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50,000 (estimated)
- Sponsor
- Shandong First Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the biomarkers for the prognosis of coronary heart disease, patients with coronary heart disease will be recruited and followed up for at least 2 years.
Detailed description
Patients with cardiovascular disease undergoing coronary angiography will be recruited and prospectively followed up for the incidence of major adverse cardiovascular events (MACE events), including all-cause mortality, cardiovascular mortality, ischemic stroke, heart failure and rehospitalization. Blood and fecal samples will be collected for further analysis. The basic and clinical information will be collected such as socio-demographic, diet, lifestyle, psychological status and medical history. The biomarkers for the incidence of coronary heart disease and the factors contributing to the poor prognosis of coronary heart disease will be investigated based on multi-omics analysis.
Conditions
Timeline
- Start date
- 2022-01-21
- Primary completion
- 2027-01-21
- Completion
- 2027-01-21
- First posted
- 2023-01-26
- Last updated
- 2023-02-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05699629. Inclusion in this directory is not an endorsement.